Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Subclinical atheroscleros… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Subclinical atherosclerosis and its progression are modulated by PLIN2 through a feed-forward loop between LXR and autophagy

Artikel i vetenskaplig tidskrift
Författare P. Saliba-Gustafsson
M. Pedrelli
K. Gertow
O. Werngren
V. Janas
S. Pourteymour
D. Baldassarre
E. Tremoli
F. Veglia
R. Rauramaa
A. J. Smit
P. Giral
S. Kurl
M. Pirro
U. de Faire
S. E. Humphries
A. Hamsten
I. Goncalves
M. Orho-Melander
A. Franco-Cereceda
Jan Borén
P. Eriksson
J. Magne
P. Parini
E. Ehrenborg
C. R. Sirtori
S. Castelnuovo
M. Amato
B. Frigerio
A. Ravani
D. Sansaro
C. Tedesco
F. Bovis
A. Discacciati
M. Ahl
G. Blomgren
M. J. Eriksson
P. Fahlstadius
M. Heinonen
L. Nilson
J. Cooper
J. Acharya
K. Huttunen
E. Rauramaa
H. Pekkarinen
I. M. Penttila
J. Torronen
A. I. van Gessel
A. M. van Roon
G. C. Teune
W. D. Kuipers
M. Bruin
A. Nicolai
P. Haarsma-Jorritsma
D. J. Mulder
H. J. G. Bilo
G. H. Smeets
J. L. Beaudeux
J. F. Kahn
V. Carreau
A. Kontush
J. Karppi
T. Nurmi
K. Nyyssonen
R. Salonen
T. P. Tuomainen
J. Tuomainen
J. Kauhanen
G. Vaudo
A. Alaeddin
D. Siepi
G. Lupattelli
G. Schillaci
Publicerad i Journal of Internal Medicine
ISSN 0954-6820
Publiceringsår 2019
Publicerad vid Wallenberglaboratoriet
Institutionen för medicin, avdelningen för molekylär och klinisk medicin
Språk en
Länkar dx.doi.org/10.1111/joim.12951
Ämnesord 27OH-cholesterol, atherosclerosis, autophagy, liver-X-receptor, PLIN2, reverse cholesterol transport, macrophage foam cells, accumulation, efflux, identification, stimulation, metabolism, receptors, ser251pro, protects, General & Internal Medicine
Ämneskategorier Kardiologi

Sammanfattning

Background Hyperlipidaemia is a major risk factor for cardiovascular disease, and atherosclerosis is the underlying cause of both myocardial infarction and stroke. We have previously shown that the Pro251 variant of perilipin-2 reduces plasma triglycerides and may therefore be beneficial to reduce atherosclerosis development. Objective We sought to delineate putative beneficial effects of the Pro251 variant of perlipin-2 on subclinical atherosclerosis and the mechanism by which it acts. Methods A pan-European cohort of high-risk individuals where carotid intima-media thickness has been assessed was adopted. Human primary monocyte-derived macrophages were prepared from whole blood from individuals recruited by perilipin-2 genotype or from buffy coats from the Karolinska University hospital blood central. Results The Pro251 variant of perilipin-2 is associated with decreased intima-media thickness at baseline and over 30 months of follow-up. Using human primary monocyte-derived macrophages from carriers of the beneficial Pro251 variant, we show that this variant increases autophagy activity, cholesterol efflux and a controlled inflammatory response. Through extensive mechanistic studies, we demonstrate that increase in autophagy activity is accompanied with an increase in liver-X-receptor (LXR) activity and that LXR and autophagy reciprocally activate each other in a feed-forward loop, regulated by CYP27A1 and 27OH-cholesterol. Conclusions For the first time, we show that perilipin-2 affects susceptibility to human atherosclerosis through activation of autophagy and stimulation of cholesterol efflux. We demonstrate that perilipin-2 modulates levels of the LXR ligand 27OH-cholesterol and initiates a feed-forward loop where LXR and autophagy reciprocally activate each other; the mechanism by which perilipin-2 exerts its beneficial effects on subclinical atherosclerosis.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?